Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2002 1
2004 9
2005 8
2006 8
2007 9
2008 5
2009 5
2010 7
2011 5
2012 7
2013 6
2014 6
2015 5
2016 7
2017 10
2018 12
2019 9
2020 12
2021 16
2022 12
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Hydrocortisone in Severe Community-Acquired Pneumonia.
Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefève G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, François B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L'Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengellé C, Caille-Fénérol C, Giraudeau B, Le Gouge A; CRICS-TriGGERSep Network. Dequin PF, et al. Among authors: gibot s. N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21. N Engl J Med. 2023. PMID: 36942789 Clinical Trial.
Hospital-acquired pneumonia in ICU.
Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar JR, Bruyère R, Chanques G. Leone M, et al. Among authors: gibot s. Anaesth Crit Care Pain Med. 2018 Feb;37(1):83-98. doi: 10.1016/j.accpm.2017.11.006. Epub 2017 Nov 15. Anaesth Crit Care Pain Med. 2018. PMID: 29155054 Free article. Review.
High versus low blood-pressure target in patients with septic shock.
Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Hervé F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P; SEPSISPAM Investigators. Asfar P, et al. N Engl J Med. 2014 Apr 24;370(17):1583-93. doi: 10.1056/NEJMoa1312173. Epub 2014 Mar 18. N Engl J Med. 2014. PMID: 24635770 Free article. Clinical Trial.
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy Study Group. Ader F, et al. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534511 Free PMC article. Clinical Trial.
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
François B, Lambden S, Fivez T, Gibot S, Derive M, Grouin JM, Salcedo-Magguilli M, Lemarié J, De Schryver N, Jalkanen V, Hicheur T, Garaud JJ, Cuvier V, Ferrer R, Bestle M, Pettilä V, Mira JP, Bouisse C, Mercier E, Vermassen J, Huberlant V, Vinatier I, Anguel N, Levy M, Laterre PF; ASTONISH investigators. François B, et al. Among authors: gibot s. Lancet Respir Med. 2023 Oct;11(10):894-904. doi: 10.1016/S2213-2600(23)00158-3. Epub 2023 May 31. Lancet Respir Med. 2023. PMID: 37269870 Clinical Trial.
Osteopontin in sepsis: any role?
Derive M, Gibot S. Derive M, et al. Among authors: gibot s. Intensive Care Med. 2008 Dec;34(12):2134-5. doi: 10.1007/s00134-008-1275-5. Epub 2008 Sep 20. Intensive Care Med. 2008. PMID: 18807010 No abstract available.
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis.
Boufenzer A, Carrasco K, Jolly L, Brustolin B, Di-Pillo E, Derive M, Gibot S. Boufenzer A, et al. Among authors: gibot s. Cell Mol Immunol. 2021 Feb;18(2):452-460. doi: 10.1038/s41423-020-00591-7. Epub 2021 Jan 8. Cell Mol Immunol. 2021. PMID: 33420354 Free PMC article.
Data-driving methods: More than merely trendy buzzwords?
Textoris J, Taccone FS, Zafrani L, Guillon A, Gibot S, Uhel F, Azabou E, Monneret G, Pène F, de Prost N, Silva S; Translational Research Committee of the French Intensive Care Society (Société de Réanimation de Langue Française, SRLF). Textoris J, et al. Among authors: gibot s. Ann Intensive Care. 2018 May 2;8(1):58. doi: 10.1186/s13613-018-0405-7. Ann Intensive Care. 2018. PMID: 29721786 Free PMC article. Review. No abstract available.
166 results